BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 22082029)

  • 1. Optimizing parameters for clinical-scale production of high IL-12 secreting dendritic cells pulsed with oxidized whole tumor cell lysate.
    Chiang CL; Maier DA; Kandalaft LE; Brennan AL; Lanitis E; Ye Q; Levine BL; Czerniecki BJ; Powell DJ; Coukos G
    J Transl Med; 2011 Nov; 9():198. PubMed ID: 22082029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside.
    Chiang CL; Kandalaft LE; Tanyi J; Hagemann AR; Motz GT; Svoronos N; Montone K; Mantia-Smaldone GM; Smith L; Nisenbaum HL; Levine BL; Kalos M; Czerniecki BJ; Torigian DA; Powell DJ; Mick R; Coukos G
    Clin Cancer Res; 2013 Sep; 19(17):4801-15. PubMed ID: 23838316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70.
    Zobywalski A; Javorovic M; Frankenberger B; Pohla H; Kremmer E; Bigalke I; Schendel DJ
    J Transl Med; 2007 Apr; 5():18. PubMed ID: 17430585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human platelet lysate is a successful alternative serum supplement for propagation of monocyte-derived dendritic cells.
    Švajger U
    Cytotherapy; 2017 Apr; 19(4):486-499. PubMed ID: 28215928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A functional comparison of mature human dendritic cells prepared in fluorinated ethylene-propylene bags or polystyrene flasks.
    Kurlander RJ; Tawab A; Fan Y; Carter CS; Read EJ
    Transfusion; 2006 Sep; 46(9):1494-504. PubMed ID: 16965575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic Cells Generated in the Presence of Platelet Lysate Have a Reduced Type 1 Polarization Capacity.
    Tešić N; Pekle Simonič I; Roškar K; Rožman P; Švajger U
    Immunol Invest; 2020 Apr; 49(3):215-231. PubMed ID: 31170833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties.
    Anguille S; Smits EL; Cools N; Goossens H; Berneman ZN; Van Tendeloo VF
    J Transl Med; 2009 Dec; 7():109. PubMed ID: 20021667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human dendritic cells engineered to express alpha tumor necrosis factor maintain cellular maturation and T-cell stimulation capacity.
    Ye Z; Chen Z; Sami A; El-Gayed A; Xiang J
    Cancer Biother Radiopharm; 2006 Dec; 21(6):613-22. PubMed ID: 17257077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ex vivo culture duration on phenotype and cytokine production by mature dendritic cells derived from peripheral blood monocytes.
    Tawab A; Fan Y; Read EJ; Kurlander RJ
    Transfusion; 2009 Mar; 49(3):536-47. PubMed ID: 19243546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a clinical-scale method for generation of dendritic cells from PBMC for use in cancer immunotherapy.
    Wong EC; Maher VE; Hines K; Lee J; Carter CS; Goletz T; Kopp W; Mackall CL; Berzofsky J; Read EJ
    Cytotherapy; 2001; 3(1):19-29. PubMed ID: 12028840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standardized generation of fully mature p70 IL-12 secreting monocyte-derived dendritic cells for clinical use.
    Spisek R; Bretaudeau L; Barbieux I; Meflah K; Gregoire M
    Cancer Immunol Immunother; 2001 Oct; 50(8):417-27. PubMed ID: 11726136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Day-4 myeloid dendritic cells pulsed with whole tumor lysate are highly immunogenic and elicit potent anti-tumor responses.
    Chiang CL; Hagemann AR; Leskowitz R; Mick R; Garrabrant T; Czerniecki BJ; Kandalaft LE; Powell DJ; Coukos G
    PLoS One; 2011; 6(12):e28732. PubMed ID: 22194898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors.
    Dauer M; Obermaier B; Herten J; Haerle C; Pohl K; Rothenfusser S; Schnurr M; Endres S; Eigler A
    J Immunol; 2003 Apr; 170(8):4069-76. PubMed ID: 12682236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1-specific CD8+ T cells identified by peptide-MHC-class-I tetramers.
    Bohnenkamp HR; Coleman J; Burchell JM; Taylor-Papadimitriou J; Noll T
    Cell Immunol; 2004; 231(1-2):112-25. PubMed ID: 15919376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a fully GMP-compliant production process of autologous, tumor-lysate-pulsed dendritic cells.
    Eyrich M; Schreiber SC; Rachor J; Krauss J; Pauwels F; Hain J; Wölfl M; Lutz MB; de Vleeschouwer S; Schlegel PG; Van Gool SW
    Cytotherapy; 2014 Jul; 16(7):946-64. PubMed ID: 24831836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engagement of human monocyte-derived dendritic cells into interleukin (IL)-12 producers by IL-1beta + interferon (IFN)-gamma.
    Nakahara T; Urabe K; Fukagawa S; Uchi H; Inaba K; Furue M; Moroi Y
    Clin Exp Immunol; 2005 Mar; 139(3):476-82. PubMed ID: 15730393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unexpected impairment of TNF-α-induced maturation of human dendritic cells in vitro by IL-4.
    Chabot V; Martin L; Meley D; Sensebé L; Baron C; Lebranchu Y; Dehaut F; Velge-Roussel F
    J Transl Med; 2016 Apr; 14():93. PubMed ID: 27080531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines.
    Schnurr M; Galambos P; Scholz C; Then F; Dauer M; Endres S; Eigler A
    Cancer Res; 2001 Sep; 61(17):6445-50. PubMed ID: 11522639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF-α and tumor lysate promote the maturation of dendritic cells for immunotherapy for advanced malignant bone and soft tissue tumors.
    Miwa S; Nishida H; Tanzawa Y; Takata M; Takeuchi A; Yamamoto N; Shirai T; Hayashi K; Kimura H; Igarashi K; Mizukoshi E; Nakamoto Y; Kaneko S; Tsuchiya H
    PLoS One; 2012; 7(12):e52926. PubMed ID: 23300824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro induction of specific anti-tumoral immunity against laryngeal carcinoma by using human interleukin-12 gene-transfected dendritic cells.
    Liang W; Wang XF
    Chin Med J (Engl); 2011 May; 124(9):1357-61. PubMed ID: 21740748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.